How can maturity-onset diabetes of the young be identified among more common diabetes subtypes?

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Wiener Klinische Wochenschrift

• Publication date

  2019-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00508-019-01543-6PMID 31493099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maturity-Onset Diabetes of the Young Overview

  2018cited by this paper
• NEUROD1‐deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features

  2018cited by this paper
• Use of oral antidiabetic drugs in the treatment of maturity‐onset diabetes of the young: A mini review

  2018cited by this paper
• A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin

  2018cited by this paper
• 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018

  2017cited by this paper
• Neonatal Diabetes

  2017cited by this paper
• Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients

  2017cited by this paper
• High Prevalence of Diabetes-Predisposing Variants in MODY Genes Among Danish Women With Gestational Diabetes Mellitus

  2017cited by this paper
• A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase‐MODY

  2016cited by this paper
• Practical Aspects of Monogenic Diabetes: A Clinical Point of View.

  2016cited by this paper
• Assessment of Newly Proposed Clinical Criteria to Identify HNF1A MODY in Patients with an Initial Diagnosis of Type 1 or Type 2 Diabetes Mellitus

  2016cited by this paper
• GCK monogenic diabetes and gestational diabetes: possible diagnosis on clinical grounds

  2015cited by this paper
• Identifying Glucokinase Monogenic Diabetes in a Multiethnic Gestational Diabetes Mellitus Cohort: New Pregnancy Screening Criteria and Utility of HbA1c

  2015cited by this paper
• Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus.

  2015cited by this paper
• Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation

  2015cited by this paper
• Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?

  2015cited by this paper
• Comment on Rudland et al. Identifying Glucokinase Monogenic Diabetes in a Multiethnic Gestational Diabetes Mellitus Cohort: New Pregnancy Screening Criteria and Utility of HbA1c. Diabetes Care 2016;39:50–52

  2015cited by this paper
• HNF1B-associated renal and extra-renal disease—an expanding clinical spectrum

  2015cited by this paper
• The 0.1% of the Population With Glucokinase Monogenic Diabetes Can Be Recognized by Clinical Characteristics in Pregnancy: The Atlantic Diabetes in Pregnancy Cohort

  2014cited by this paper
• Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level

  2014cited by this paper
• De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed

  2014cited by this paper
• Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

  2014cited by this paper
• Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia

  2013cited by this paper
• Use of HbA1c in the Identification of Patients with Hyperglycaemia Caused by a Glucokinase Mutation: Observational Case Control Studies

  2013cited by this paper
• Chronic Mild Hyperglycemia in GCK-MODY Patients Does Not Increase Carotid Intima-Media Thickness

  2013cited by this paper
• Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes

  2013cited by this paper
• Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration

  2013cited by this paper
• Metabolic Syndrome and Obesity : Targets and Therapy Clinical features and treatment of maturity onset diabetes of the young ( MODY )

  2012cited by this paper
• Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young

  2012cited by this paper
• MODY

  2011cited by this paper
• Heterozygous ABCC8 mutations are a cause of MODY

  2011cited by this paper
• GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.

  2011cited by this paper
• Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene.

  2011cited by this paper
• MODY: history, genetics, pathophysiology, and clinical decision making.

  2011cited by this paper
• High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes

  2011cited by this paper
• Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60.

  2010cited by this paper
• Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene

  2010cited by this paper
• Mutations at the BLK locus linked to maturity onset diabetes of the young and β-cell dysfunction

  2009cited by this paper
• Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes

  2008cited by this paper
• Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young

  2008cited by this paper
• Insulin Mutation Screening in 1,044 Patients With Diabetes

  2008cited by this paper
• PAX4 mutations in Thais with maturity onset diabetes of the young.

  2007cited by this paper
• Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A Gene

  2007cited by this paper
• The rise and fall of insulin secretion in type 1 diabetes mellitus

  2006cited by this paper
• Hepatocyte nuclear factor‐1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF‐1β in human pancreatic development

  2006cited by this paper
• Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient

  2006cited by this paper
• Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction

  2006cited by this paper
• Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function.

  2005cited by this paper
• Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β Mutations

  2004cited by this paper
• Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations.

  2004cited by this paper
• High frequency of mutations in the HNF-1α gene in non-obese patients with diabetes of youth in Japanese and identification of a case of digenic inheritance

  2002cited by this paper
• The genetic abnormality in the beta cell determines the response to an oral glucose load

  2002cited by this paper
• Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor‐1α gene mutations: evidence for pharmacogenetics in diabetes

  2000cited by this paper
• Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus

  1999cited by this paper

• Biomarkers: Tools for Discriminating MODY from Other Diabetic Subtypes

  2022cites this paper
• ABCC8 variants in MODY12: Review of the literature and report of a case with severe complications

  2021influential citation
• Current Perspectives in MODY Management—A Narrative Review

  2021cites this paper
• Update on clinical screening of maturity-onset diabetes of the young (MODY)

  2020cites this paper
• Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment

  2020cites this paper